|
Jun 29
|
Why Shares of Opko Health Jumped on Thursday
|
|
Jun 29
|
OPKO Health's (OPK) NGENLA Approved by FDA for GHD Treatment
|
|
Jun 29
|
Disney downgraded, Micron upgraded: Wall Street's top analyst calls
|
|
Jun 29
|
Pfizer (PFE) Gets FDA Nod for Growth Hormone Deficiency Drug
|
|
Jun 28
|
UPDATE 3-Pfizer-OPKO's growth hormone drug gets US approval in kids
|
|
Jun 28
|
FDA Approves Pfizer’s NGENLA™, a Long-Acting Once-Weekly Treatment for Pediatric Growth Hormone Deficiency
|